ENTRY       D06475                      Drug
NAME        Adsorbed hepatitis B vaccine (JP18);
            Bimmugen (TN)
PRODUCT     ENGERIX-B (GlaxoSmithKline Biologicals SA)
            PREHEVBRIO (VBI Vaccines (Delaware))
            RECOMBIVAX HB (Merck Sharp & Dohme LLC)
REMARK      Therapeutic category: 6313
            ATC code: J07BC01
            Product: D06475<JP/US>
EFFICACY    Active immunization (hepatitis B)
INTERACTION  
STR_MAP     map07044  Antiviral agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J07 VACCINES
               J07B VIRAL VACCINES
                J07BC Hepatitis vaccines
                 J07BC01 Hepatitis B, purified antigen
                  D06475  Adsorbed hepatitis B vaccine (JP18) &lt;JP/US&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               631  Vaccines
                6313  Viral vaccines
                 D06475  Adsorbed hepatitis B vaccine (JP18)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D06475  Adsorbed hepatitis B vaccine
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D06475
DBLINKS     PubChem: 47208131
///
